Skip to main content
Equibles
ADMT logo

ADMT · Adm Tronics Unlimited, Inc. · Metrics

Track ADMT — free

Use ADMT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADMT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.05 +0.00 (+4.17%) At close · Oct 20
Rebalance outlook locked
Going-concern doubt — flagged Aug 19, 2026

Substantial doubt about the company's ability to continue as a going concern.

“There is substantial doubt that the funding plans will be successful and therefore the conditions discussed above have not been alleviated. As a result, there is substantial doubt about the Company’s ability to continue as a going concern for one year from August 19, 2026, the date the financial statements were available to be issued.”
View the 10-Q filed Aug 19, 2026
Market Cap
$3.38M
Shares
67.59M
Volume · Oct 20 100 Avg daily vol (3M) 6601

ADMT metrics

75 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.05
Market cap
$3.38M

Price action

20 metrics
Price change (1W)
+20.5%
Price change (30D)
+0.0%
Price change (3M)
+25.0%
Price change (6M)
-37.5%
Price change (YTD)
-50.0%
Price change (1Y)
-44.4%
Trailing year
Price change (5Y)
-54.5%
52-week high
$0.12
52-week low
$0.03
Change from 52-week high
-58.3%
Change from 52-week low
+66.7%
Annualized volatility
241.7%
Annualized volatility (3M)
—
Beta
-1.1
RSI (14D)
54.2
Price vs SMA 50
+19.8%
Price vs SMA 200
-31.4%
Avg volume (3M)
6,601
Relative volume
0.0
Average dollar volume
$262

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
67.59M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.1×
reciprocal yield 89.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.0×
reciprocal yield 95.9%
P / book
5.6
reciprocal yield 17.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-11.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.5×
reciprocal yield 67.5%
EV / revenue historical average (5Y)
1.6×
reciprocal yield 61.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
39.2%
Operating margin
-8.9%
Trailing 12 months
Net margin
-12.2%
Gross profit (TTM)
$1.27M
Operating profit (TTM)
−$288,986
Net income (TTM)
−$395,644
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.05
Gross profit per diluted share (TTM)
$0.02
Operating profit per diluted share (TTM)
$-0.02
EBITDA per diluted share (TTM)
$-0.02
Net income per diluted share (TTM)
$0.00
Operating cash flow per diluted share (TTM)
$-0.01
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.01
Stock compensation per diluted share (TTM)
—
Book value per share
$0.01

Growth

11 metrics
Revenue growth YoY
-11.0%
Year over year
Net income growth YoY
-90.1%
Revenue (TTM)
$3.24M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
-3.1%
Revenue CAGR (5Y)
+1.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-65.6%
Return on assets
-19.6%
Debt / equity
0.7
Current ratio
1.0
EBITDA (TTM)
−$282,270
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$226,232
Latest balance sheet
Cash & equivalents
$222,619
Total assets
$2.02M
Total debt
$448,851

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$142,218
Capital expenditures (TTM)
—
R&D (TTM)
$522,649
SG&A (TTM)
$1.04M
Stock compensation (TTM)
$0
R&D / revenue
16.1%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
1
13F filer change QoQ
0
Institutional ownership
0.1%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.0%
Holder tenure
7.0
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.1 days to cover
Days to cover
1.1d
Short-squeeze score
42 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 849401 CUSIP 001004100 Visit website Investor relations